Prometheus Biosciences Financials
RXDXDelisted Stock | USD 199.92 0.24 0.12% |
Prometheus |
Understanding current and past Prometheus Biosciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Prometheus Biosciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Prometheus Biosciences' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Prometheus Biosciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Prometheus Biosciences. Check Prometheus Biosciences' Beneish M Score to see the likelihood of Prometheus Biosciences' management manipulating its earnings.
Prometheus Biosciences Stock Summary
Prometheus Biosciences competes with Apellis Pharmaceuticals, Akero Therapeutics, Immunovant, Madrigal Pharmaceuticals, and Roivant Sciences. Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases . Prometheus Biosciences, Inc. was incorporated in 2016 and is headquartered in San Diego, California. Prometheus Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 72 people.Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US74349U1088 |
Business Address | 9410 Carroll Park |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.prometheusbiosciences.com |
Phone | 858 684 1300 |
Currency | USD - US Dollar |
Prometheus Biosciences Key Financial Ratios
Return On Equity | -0.33 | |||
Return On Asset | -0.2 | |||
Target Price | 190.0 | |||
Number Of Employees | 97 | |||
Beta | -0.49 |
Prometheus Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Prometheus Biosciences's current stock value. Our valuation model uses many indicators to compare Prometheus Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Prometheus Biosciences competition to find correlations between indicators driving Prometheus Biosciences's intrinsic value. More Info.Prometheus Biosciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Prometheus Biosciences' earnings, one of the primary drivers of an investment's value.Prometheus Biosciences Market Pulse
Quote | 199.92 |
Change(%) | 0.12 |
Change | 0.24 |
Open | 199.68 |
Low | 199.6 |
High | 199.98 |
Volume | 0 |
Exchange | NASDAQ |
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Prometheus Biosciences is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Prometheus has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Prometheus Biosciences' financials are consistent with your investment objective using the following steps:- Review Prometheus Biosciences' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Prometheus Biosciences' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Prometheus Biosciences' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Prometheus Biosciences' stock is overvalued or undervalued.
Prometheus Biosciences Thematic Clasifications
Prometheus Biosciences is part of Cancer Fighters investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Public companies from health care and pharmaceutical sectors that are focused on fighting cancer. Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases
This theme covers Public companies from health care and pharmaceutical sectors that are focused on fighting cancer. Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases. Get More Thematic Ideas
Cancer Fighters | View |
Prometheus Biosciences November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Prometheus Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Prometheus Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Prometheus Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Prometheus Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Prometheus Biosciences's daily price indicators and compare them against related drivers.
Downside Deviation | 1.83 | |||
Information Ratio | 0.1049 | |||
Maximum Drawdown | 70.71 | |||
Value At Risk | (3.26) | |||
Potential Upside | 2.76 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Prometheus Stock
If you are still planning to invest in Prometheus Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Prometheus Biosciences' history and understand the potential risks before investing.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |